CURAGEN CORP
10-Q, 1999-11-02
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CURAGEN CORP, 10-Q, 1999-11-02
Next: WORLD WIRELESS COMMUNICATIONS INC, 10-Q/A, 1999-11-02

EXHIBIT 11

CURAGEN CORPORATION
COMPUTATION OF NET LOSS PER SHARE
ATTRIBUTABLE TO COMMON STOCKHOLDERS
(unaudited)

Three Months Ended
September 30,
Nine Months Ended
September 30,


1999 1998 1999 1998




Net loss $(5,147,393 ) $(4,511,685 ) $(18,279,463 ) $(10,178,215 )
Preferred dividends -- -- -- (508,435 )




                 
Net loss attributable to common stockholders $(5,147,393 ) $(4,511,685 ) $(18,279,463 ) $(10,686,650 )




Basic and diluted net loss per share attributable to
   common stockholders $          (0.37 ) $          (0.34 ) $          (1.34 ) $          (0.90 )




Weighted average number of shares used in computing
   basic and diluted net loss per share attributable to
   common stockholders 13,998,362 13,203,058 13,614,835 11,831,393






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission